GIOVANNETTI, ELISA
GIOVANNETTI, ELISA
Aberrant expression of PTEN in squamous lung cancer cells: molecular analysis and impact on the synergistic combination of the targeted therapy with BKM120 and Defactinib
2015-01-01 Cavazzoni, A; Giovannetti, E; Alfieri, R; Caraffini, Veronica; Tiseo, M; Sciarrillo, R; Ardizzoni, A; Petronini, Pg.
Effect of dual PI3K and FAK inhibition in squamous lung carcinoma with reduced PTEN level
2016-01-01 Cavazzoni, A; Giovannetti, E; Alfieri, R; Sciarrillo, R; Van der Steen, N; Tiseo, M; Ardizzoni, Andrea; Petronini, Pg.
MicroRNA as predictive biomarkers for drug resistance and sensitivity in colorectal cancer
2017-01-01 G. Li, Phd1; Cavazzoni, Andrea; Phd, ; Giovannetti, Elisa; Md, ; Phd, ; Barbera, M. A.; Md, ; Frega, Giuseppe Corrado; Md, ; Biasco, G.; Md, ; Garajová, I.; Md, ; Phd,
Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells
2017-01-01 Van Der Steen, Nele; Potze, Lisette; Giovannetti, Elisa; Cavazzoni, Andrea; Ruijtenbeek, Rob; Rolfo, Christian; Pauwels, Patrick; Peters, GODEFRIDUS JOHANNES
New treatment opportunities in phosphatase and tensin homolo(PTen)-deficient tumors: Focus on PTen/focal adhesion kinase pathway
2017-01-01 Alfieri, Roberta; Giovannetti, Elisa; Bonelli, Mara; Cavazzoni, Andrea
Synergistic effect of PI3K and FAK inhibition in squamous lung cancer cells with reduced PTEN level
2017-01-01 Cavazzoni, A; La Monica, S; Alfieri, R; Sciarrillo, R; Cretella, D; Van der Steen, N; Tiseo, M; Ardizzoni, A; Petronini, Pg; Giovannetti, E.
Targeting oncogenic PI3K/Akt/mTOR pathway in squamous cell lung carcinoma
2016-01-01 Cavazzoni, A; Giovannetti, E; Alfieri, R; Cretella, D; Bonelli, M; Fumarola, C; La Monica, S; Sciarrillo, R; Tiseo, M; Ardizzoni, A; Peters, Gj; Petronini, Pg.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Aberrant expression of PTEN in squamous lung cancer cells: molecular analysis and impact on the synergistic combination of the targeted therapy with BKM120 and Defactinib | 1-gen-2015 | Cavazzoni, A; Giovannetti, E; Alfieri, R; Caraffini, Veronica; Tiseo, M; Sciarrillo, R; Ardizzoni, A; Petronini, Pg. | |
| Effect of dual PI3K and FAK inhibition in squamous lung carcinoma with reduced PTEN level | 1-gen-2016 | Cavazzoni, A; Giovannetti, E; Alfieri, R; Sciarrillo, R; Van der Steen, N; Tiseo, M; Ardizzoni, Andrea; Petronini, Pg. | |
| MicroRNA as predictive biomarkers for drug resistance and sensitivity in colorectal cancer | 1-gen-2017 | G. Li, Phd1; Cavazzoni, Andrea; Phd, ; Giovannetti, Elisa; Md, ; Phd, ; Barbera, M. A.; Md, ; Frega, Giuseppe Corrado; Md, ; Biasco, G.; Md, ; Garajová, I.; Md, ; Phd, | |
| Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells | 1-gen-2017 | Van Der Steen, Nele; Potze, Lisette; Giovannetti, Elisa; Cavazzoni, Andrea; Ruijtenbeek, Rob; Rolfo, Christian; Pauwels, Patrick; Peters, GODEFRIDUS JOHANNES | |
| New treatment opportunities in phosphatase and tensin homolo(PTen)-deficient tumors: Focus on PTen/focal adhesion kinase pathway | 1-gen-2017 | Alfieri, Roberta; Giovannetti, Elisa; Bonelli, Mara; Cavazzoni, Andrea | |
| Synergistic effect of PI3K and FAK inhibition in squamous lung cancer cells with reduced PTEN level | 1-gen-2017 | Cavazzoni, A; La Monica, S; Alfieri, R; Sciarrillo, R; Cretella, D; Van der Steen, N; Tiseo, M; Ardizzoni, A; Petronini, Pg; Giovannetti, E. | |
| Targeting oncogenic PI3K/Akt/mTOR pathway in squamous cell lung carcinoma | 1-gen-2016 | Cavazzoni, A; Giovannetti, E; Alfieri, R; Cretella, D; Bonelli, M; Fumarola, C; La Monica, S; Sciarrillo, R; Tiseo, M; Ardizzoni, A; Peters, Gj; Petronini, Pg. |